Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT 48.60
+0.20 (0.41%)
At close: Jun 4, 2025
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 5.22 billion as of June 13, 2025. Its market cap has decreased by -45.64% in one year.
Market Cap
5.22B
Enterprise Value
9.95B
Revenue
8.47B
Ranking
n/a
PE Ratio
11.65
Stock Price
48.60
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 5.22B, an increase of 84.09%. That is a compound annual growth rate of 26.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 5.22B | - |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grameenphone | 386.46B |
| Square Pharmaceuticals PLC. | 179.77B |
| British American Tobacco Bangladesh Company | 144.18B |
| Robi Axiata PLC. | 125.71B |
| Walton Hi-Tech Industries | 120.99B |
| BRAC Bank PLC. | 109.75B |
| Bangladesh Export Import Company | 103.85B |
| Berger Paints Bangladesh | 80.34B |